loader2
Partner With Us NRI

Balaxi Pharmaceuticals Ltd share Price Today

Company details

574.90
578.35
399.95
686.30
6M Return 36.09%
1Y Return 8.38%
Mkt Cap.(Cr) 589.04
Volume 143
Div Yield 0.00%
OI
-
OI Chg %
-
Volume 143

Open Free Trading Account Online with ICICIDIRECT

Incur '0' Brokerage upto ₹500

Balaxi Pharmaceuticals Ltd shares SWOT Analysis

Strengths (5)

  • Strong Momentum: Price above short, medium and long term moving averages
  • Company with Low Debt
  • Company able to generate Net Cash - Improving Net Cash Flow for last 2 years

Weakness (7)

  • Promoter holding decreased by more than -2% QoQ
  • Negative profit growth, promoters decreasing shareholding QoQ
  • Inefficient use of capital to generate profits - RoCE declining in the last 2 years

Opportunity (2)

  • Stock with Low PE (PE < = 10)
  • RSI indicating price strength

Threats (2)

  • Promoter decreasing their shareholding
  • Companies with growing costs YoY for long term projects

Resistance and support

R1 582.5
R2 589.7
R3 599.4
Pivot

572.83

S1 565.7
S2 556.0
S3 548.8
EMA SMA
562.9
542.9
517.7
502.7
560.4
562.2
499.5
479.0
Delivery and volume
CLIENT NAME DEAL TYPE ACTION DATE AVG. PRICE QUANTITY EXCHANGE
AMOL ANAND MANTRI Bulk Sell 2020-08-03 259.05 178450 NSE
ALAGAPPAN V. Bulk Sell 2019-04-30 94.83 20000 NSE
Name Category Shares
ASHISH MAHESHWARI PROMOTER 1.65%
MINOSHI MAHESHWARI PROMOTER 0.96%
Bodies Corporate PROMOTER 63.75%
BALAXI OVERSEAS PRIVATE LIMITED PROMOTER 63.75%

FINANCIALS

Sales
Operating Profit
Profit after Tax
Equity
Reserves and Surplus
Debt
Sales
Operating Profit
Profit after Tax
PE
Debt/Equity
P BV

Balaxi Pharmaceuticals Ltd Stocks COMPARISON

Financials( in Cr) Balaxi Pharmaceuticals Ltd Adani Enterprises Ltd Aegis Logistics Ltd Cello World Ltd Redington Ltd
Price 575.80 3,101.00 599.20 940.00 224.50
% Change 0.08 -0.46 -0.16 1.12 0.40
Mcap Cr 589.04 353,514.31 21,031.92 19,949.71 17,550.83
Revenue TTM Cr 336.43 69,420.18 8,627.21 1,796.70 79,376.78
Net Profit TTM Cr 45.96 475.37 510.70 285.07 1,439.39
PE TTM 19.14 93.87 41.01 74.05 14.50
1 Year Return 8.38 68.11 50.67 18.73 32.84
ROCE 37.25 6.57 17.08 45.20 25.43
ROE 31.05 2.41 17.88 134.44 22.65
INSIDER & INSTITUTIONAL ACTIVITY

Equity Capital: 172.58 Cr FV: 10.00

Period MF Net Purchase / (sold) FII Net
LAST 1M 20,210.21 -2,288.40
LAST 3M 84,754.55 29,178.29
LAST 6M 143,739.62 78,000.86
LAST 12M 219,616.53 194,185.36

Balaxi Pharmaceuticals Ltd Information

Stock PE (TTM)
19.14
Promoter Holding
71.22%
Book Value
170.2902
ROCE
37.25%
ROE
31.05%
Description
  • Balaxi Ventures Limited (erstwhile known as The Anandam Rubber Company Limited) is a public limited company incorporated in India in September 28, 1942 with a basic objective of running rubber and tea plantations and owns several plantations across South India. In the year 1989 the company sold its entire plantations to meet the emerging business needs and started concentrating in Investments and trading. The company previously was a investment company, but the company during the financial year 2018-19 has commenced the business of International Wholesale Trading of Pharmaceuticals, Builders Hardware and FMCG Products Securities and Exchange Board of India (SEBI) vide Circular dated May 30, 2012 had issued revised Exit Policy for de-recognized/non-operational stock exchanges. Pursuant to the circular, Madras Stock Exchange has been de-recognized by SEBI, recently. Further, as per above cited circular issued by SEBI on May 30, 2012, and Public Notice issued by Madras Stock Exchange Limited (MSE), it cleared that the Exclusively Listed Companies, which fail to obtain listing on any other stock exchange, will cease to be a listed company and will be moved to the Dissemination Board by the exiting stock exchange. Also, it is to be noted that SEBI has given a time limit of eighteen months for getting listed with any of the recognized stock exchanges. In pursuance to the above notice, the company has submitted listing application with National Stock Exchange of India (NSE) Limited on 19th January 2015 under listing criteria for Exclusively Listed Companies. The submitted listing application is under process with the National Stock Exchange of India (NSE) Limited and the company is hoping to be get listed very soon. Madras Stock Exchange has intimated the Company that it has been placed before Dissemination Board (DB) of National Stock Exchange of India (NSE) Limited. Under the Dissemination Board mechanism, a willing buyer and seller will be given an opportunity to disseminate their offers using the services of brokers of stock exchanges hosting Dissemination Board. On 15 March 2017, Balaxi Overseas Private Limited (BOPL) entered into a Share Purchase Agreement (SPA) with the erstwhile promoters of Company (i.e. Mr. Nirej V. Paul, Mr. V. M. Paulose, Dr. Leelamma T. J and Mrs. Jaya Paul) to acquire 1,670,036 Equity Shares representing 54.94% of the paid up share capital of the Company along with the control over the Company, pursuant to which BOPL made an Open Offer under Regulation 3(1) and Regulation 4 of SEBI (SAST) Regulations, 2011. Control and management of the Company was acquired by BOPL on May 04, 2017 and it became the new promoter of Company and their representatives i.e. Mr. Ashish Maheshwari and Mrs. Minoshi Maheshwari became the new Directors of the Company. Simultaneously, erstwhile promoters stepped down as promoters from Company on same day and Mr. Nirej V. Paul and Dr. Leelamma TJ resigned as Managing Director and as Chairperson from the Company, respectively. Under the above said Open Offer, BOPL acquired 3,30,000 equity shares representing 10.86% equity share capital of the Company. On completion of the Open Offer BOPL became the holding and Promoter Company with an aggregate shareholding of 2000036 Equity Shares (ie 65.79%). The Company changed its name from `The Anandam Rubber Company Limited` to `Balaxi Ventures Limited` through Postal Ballot passed on August 08, 2017. It had also changed the Registered Office from 41/298 - D2, 2nd Floor, Saniya Plaza, Mahakavi Bharathiyar Road, Near KSRTC Bus Stand, Cochin - 682035 to Plot No.409, H.No. 8-2-293, MAPS Towers, 3rd Floor, Phase-III, Road No.81, Jubilee Hills, Hyderabad, Telangana, India -500096 through Postal Ballot passed on August 08, 2017. The main objects of the company were amended to include activities of International wholesale trading in pharmaceutical, food products and builders` hardware by way of a Postal Ballot passed on August 08, 2018. The Company commenced the business of international wholesale trading in pharmaceuticals and builders` hardware products starting September 2018. Further, in February 2019, The Company decided to kickstart its Food Products business by launching a range of biscuits under the brand YAP`. The Board of the company approved the proposed preferential issue of 69,60,000 Equity shares on June 19, 2019 and subsequently obtained shareholder`s approval on July 12, 2019 via Extra Ordinary General Meeting. The Company had obtained required approvals from stock exchange and allotted 69,60,000 Equity shares on preferential basis on August 09, 2019. Consequently, the Paid up share capital of the company has been accordingly increased from Rs 3,04,00,000/- consisting of 30,40,000 Equity shares of Rs 10/- each to Rs 10,00,00,000/- consisting of 1,00,00,000 Equity shares of Rs 10/- each.

Registered Address

41/298-D2 2nd Flr Saniya Plaza, Mahakavi Bharatiyar Road, Kochi, Kerala, 682035

Tel : 91-484-4032952/6596725
Email : secretarial:anandamrubberco.com
Website : http://www.balaxipharma.in
Registrar

SKDC Consultants Ltd

AGM Date (Month) : Aug
Face Value Equity Shares : 10
Market Lot Equity Shares : 1
BSE Code : 532597
NSE Code : BALAXI
Book Closure Date (Month) :
BSE Group :
ISIN : INE618N01014

FAQ’s on Balaxi Pharmaceuticals Ltd Shares

You can buy Balaxi Pharmaceuticals Ltd shares through a brokerage firm. ICICIdirect is a registered broker through which you can place orders to buy Balaxi Pharmaceuticals Ltd Share.

Company share prices and volatile and keep changing according to the market conditions. As of Apr 26, 2024 09:54 AM the closing price of Balaxi Pharmaceuticals Ltd was ₹ 575.80.

Market capitalization or market cap is determined by multiplying the current market price of a company’s shares with the total number of shares outstanding. As of Apr 26, 2024 09:54 AM, the market cap of Balaxi Pharmaceuticals Ltd stood at ₹ 589.04.

The latest PE ratio of Balaxi Pharmaceuticals Ltd as of Apr 26, 2024 09:54 AM is 19.14

The latest PB ratio of Balaxi Pharmaceuticals Ltd as of Apr 26, 2024 09:54 AM is 0.30

The 52-week high of Balaxi Pharmaceuticals Ltd share price is ₹ 686.30 while the 52-week low is ₹ 399.95

Download Our

Download App
market app